#Tirzepatide
Articles tagged #Tirzepatide on Vitalspell.
Why exercise matters more on GLP-1 drugs as the evidence shifts
GLP-1 drugs can help weight loss, but the emerging evidence suggests they should not make exercise optional.
Retatrutide phase 3 diabetes data: what it shows now
Retatrutide phase 3 diabetes data showed large A1c and weight reductions, but placebo control leaves key comparison questions open.
GLP-1 fiber: what a 2026 review actually says
GLP-1 fiber advice may help some people manage satiety and GI side effects, but the 2026 review does not prove a booster effect.
GLP-1 fiber: what a 2026 review actually says
GLP-1 fiber advice may help some people manage satiety and GI side effects, but the 2026 review does not prove a booster effect.
GLP-1 knee replacement study: what it really found
GLP-1 knee replacement data suggests lower surgery risk after long use, but the osteoarthritis study cannot prove the drugs protect joints.
More
GLP-1 drugs and blood pressure: what 43,000 patients show
GLP-1 drugs and blood pressure are linked in a 32-trial meta-analysis, but most of the drop appears to come from weight loss rather than a direct drug effect.
GLP-1 receptor agonists reduce sleep apnea severity by 14 events per hour
A 2026 meta-analysis of four randomized controlled trials finds that GLP-1 receptor agonists reduce the apnea-hypopnea index by 13.9 events per hour, lower body weight by 12.5 kg, and improve blood pressure in patients with obstructive sleep apnea and obesity.